MedinCell S.A.
OTC: MDCLF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Christophe Douat
- Employees
- 131
- Headquarters
- Jacou, France
- IPO year
- 2021
- Market cap
- $1.2B
- Website
- https://www.medincell.com
Loading MDCLF…
Loading profile data…Frequently asked questions about MDCLF
What does MedinCell S.A. (MDCLF) do?
MedinCell S.A. is a pharmaceutical company dedicated to creating a diverse array of medical treatments. At the heart of its innovation is the BEPO platform, a unique technology designed for long-acting injectable drugs. This system utilizes specific proprietary copolymers alongside a compatible solvent to effectively dissolve or suspend active p...
Where does MDCLF trade?
MedinCell S.A. (MDCLF) trades on the Other OTC.
What sector is MDCLF in?
MedinCell S.A. (MDCLF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of MedinCell S.A.?
Christophe Douat is the chief executive officer of MedinCell S.A. (MDCLF).
Where is MedinCell S.A. headquartered?
MedinCell S.A. is headquartered in France.
Does MDCLF pay a dividend?
MedinCell S.A. (MDCLF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did MDCLF go public?
MedinCell S.A. (MDCLF) completed its initial public offering in 2021.